Efficacy and safety of a novel rFIX (BAX326): phase III study in previously treated patients with severe or moderately severe hemophilia B undergoing surgical or other invasive procedures

Jerzy Windyga, Toshko Lissitchkov, Oleksandra Stasyshyn, Vasily Mamonov, Helieh Ghandehari, Miranda Chapman, Sandor Fritsch, Borislava G. Pavlova, Wing-Yen Wong, Brigitt E. Abbuehl